← Open Payments lookup

SUSAN BOEHNKE: Open Payments

NPI 1033692843 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,352 in 22 payments from 14 companies in 2025. Trend: 2023 $366 · 2024 $1,162 · 2025 $1,352

Food & beverage: $1,352
CompanyPaymentsAmount
GENZYME CORPORATION4$297
ABBVIE INC.3$147
Aimmune Therapeutics, Inc.1$125
Ardelyx, Inc.1$124
Corcept Therapeutics1$123
Celltrion USA Inc.1$120
Axsome Therapeutics, Inc.1$117
Phathom Pharmaceuticals, Inc.1$113
Regeneron Healthcare Solutions, Inc.3$73
Takeda Pharmaceuticals U.S.A., Inc.2$48

Products named: DUPIXENT, ZENPEP, RINVOQ, IBSRELA, Korlym, CERDELGA, VEGZELMA, Auvelity.

Industry payments across TX — which companies pay providers there.